Omega-3 Fatty Acid Supplementation in the Primary and Secondary Prevention of Cardiovascular Events: NEW INSIGHTS

Thomas F O'Connell; Justin Trivax; Barry A Franklin

doi:10.1097/HCR.0000000000000608

Omega-3 Fatty Acid Supplementation in the Primary and Secondary Prevention of Cardiovascular Events: NEW INSIGHTS

J Cardiopulm Rehabil Prev. 2021 May 1;41(3):137-140. doi: 10.1097/HCR.0000000000000608.

Authors

Thomas F O'Connell¹, Justin Trivax, Barry A Franklin

Affiliation

¹ Department of Cardiovascular Medicine, Beaumont Health System, Royal Oak, Michigan (Drs O'Connell, Trivax, and Franklin); and Oakland University William Beaumont School of Medicine, Rochester, Michigan (Drs Trivax and Franklin).

PMID: 33907071
DOI: 10.1097/HCR.0000000000000608

Abstract

Omega-3 fatty acid (O-3FA) supplementation has garnered interest since cardioprotective properties of dietary fish consumption were observed. In the general population, O-3FA supplementation has not improved cardiovascular outcomes. However, icosapent ethyl, a high-dose, purified form of eicosapentaenoic acid, has demonstrated additive cardioprotection to statins in high-risk patients with elevated triglycerides.

MeSH terms

Animals
Cardiovascular Diseases* / prevention & control
Dietary Supplements
Fatty Acids, Omega-3* / therapeutic use
Humans
Risk Factors
Secondary Prevention

Substances

Fatty Acids, Omega-3